BridgeBio Oncology Therapeutics Inc.
- BBOT
- NASDAQ
- Biotechnology
- Oncology Small Molecules (RAS/PI3K)
- Cancer Therapeutics
$2.82
Today −4.41%Quote Oct 16, 2026, 08:00 PM UTC
−42.33%over the last month
Max drawdown −42.3%From 1-month high −42.3%3 months −66.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$226.1M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$19.00
+573.8% from here
Floor
$2.48
11.9% below price
Where the price sits
8 analysts
Analyst range, low to high
$15.00$22.00
- Price $2.82
- Resistance $2.88
- Consensus $19.00
The price is right under resistance. Analysts' average target sits about 574% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BBOTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
88
Founded
2016